| Title : In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMMSB (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate) and QMiPSB (quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate) including isozyme mapping and carboxylesterases activity testing - Richter_2022_Drug.Test.Anal__ |
| Author(s) : Richter MJ , Wagmann L , Kavanagh PV , Brandt SD , Meyer MR |
| Ref : Drug Test Anal , : , 2022 |
| Abstract : Richter_2022_Drug.Test.Anal__ |
| ESTHER : Richter_2022_Drug.Test.Anal__ |
| PubMedSearch : Richter_2022_Drug.Test.Anal__ |
| PubMedID: 36239626 |
Richter MJ, Wagmann L, Kavanagh PV, Brandt SD, Meyer MR (2022)
In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMMSB (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate) and QMiPSB (quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate) including isozyme mapping and carboxylesterases activity testing
Drug Test Anal
:
Richter MJ, Wagmann L, Kavanagh PV, Brandt SD, Meyer MR (2022)
Drug Test Anal
: